“…Several studies of ADD uptake in brain have indicated uneven distribution in experimental animals given single and/or multiple dosings [7,11,16,20,25,27]. However, it seems that the designs of these studies, which imply intravenous or intraperitoneal administration, are not ade quate for comparison with the situation in humans, in whom steady-state serum levels of ADDs are attained [22], To our knowl edge there has been only our report concern ing the heterogeneous ADD distribution in brain under the chronic steady-state condi tion [17], This method is suitable for investi gating detailed serial changes in the regional distribution of ADD in the brain under chronic administration, as fluctuations in ADD serum concentrations can be mini mized during long-term experiments. In the previous study we examined changes in the regional brain distribution of clomipramine (CMP), a strong tricyclic serotonin uptake blocker, under long-term infusion.…”